Trials / Recruiting
RecruitingNCT06305676
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Investigators seek to determine the sensitivity and specificity of a combined HPV 16 DNA and host gene methylation oral biomarker panel to distinguish early Oropharyngeal Cancer (OPC) cases from controls among 100 early and 100 late disease pre-treatment OPC cases, and 200 controls matched by sex, age, race/ethnicity, and tobacco use collected from the Moffitt Cancer Center (Moffitt) and the University of Pittsburgh Medical Center Hillman Cancer Center (Pittsburgh).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | combined HPV 16 DNA and host gene methylation oral biomarker panel | DNA Methylation Profiling |
Timeline
- Start date
- 2024-01-22
- Primary completion
- 2029-01-01
- Completion
- 2029-01-01
- First posted
- 2024-03-12
- Last updated
- 2026-02-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06305676. Inclusion in this directory is not an endorsement.